Evidence map›Paper›PMID 36830724›Full record

ArticleBiomolecules2023

Systematic Assessment of Protein C-Termini Mutated in Human Disorders.

Zachary T FitzHugh, Martin R Schiller

Open access · goldAbstract read
In one paragraph

Article in Biomolecules, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Hemoglobin San Diego: A Case Report and Review of the Literature.The American journal of case reports · 2026
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Zachary T FitzHughNevada Institute of Personalized Medicine, University of Nevada Las Vegas, 4505 S. Maryland Pkwy, Las Vegas, NV 89154, USA.ORCID 0000-0003-4057-1804
Martin R SchillerNevada Institute of Personalized Medicine, University of Nevada Las Vegas, 4505 S. Maryland Pkwy, Las Vegas, NV 89154, USA.ORCID 0000-0003-1671-6823
University of Nevada, Las Vegas · US

Funding

Outreach/Diversity/Pipeline ProjectP20GM103440 · NIGMS · UNIVERSITY OF NEVADA RENO · PI Eduardo A Robleto · 2012 to 2026
$58.0M
The Genome Analysis and Sequencing Pipeline (GASP)P20GM121325 · NIGMS · UNIVERSITY OF NEVADA LAS VEGAS · PI CHEN, JINGCHUN · 2018 to 2022
$11.5M
Efficient Algorithms for Motif SearchR01LM010101 · NLM · UNIVERSITY OF CONNECTICUT STORRS · PI RAJASEKARAN, SANGUTHEVAR · 2010 to 2013
$1.4M
Building motif lexiconsR01GM079689 · NIGMS · UNIVERSITY OF NEVADA LAS VEGAS · PI SCHILLER, MARTIN R · 2007 to 2010
$1.1M
The C-terminomeR15GM107983 · NIGMS · UNIVERSITY OF NEVADA LAS VEGAS · PI SCHILLER, MARTIN R · 2013 to 2013
$443k
NIGMS NIH HHS P20 GM103440NIGMS NIH HHS P20 GM121325NIGMS NIH HHS R01 GM079689NIGMS NIH HHS R15 GM107983NLM NIH HHS R01 LM010101
6 · The paper itself

Abstract

All proteins have a carboxyl terminus, and we previously summarized eight mutations in binding and trafficking sequence determinants in the C-terminus that, when disrupted, cause human diseases. These sequence elements for binding and trafficking sites, as well as post-translational modifications (PTMs), are called minimotifs or short linear motifs. We wanted to determine how frequently mutations in minimotifs in the C-terminus cause disease. We searched specifically for PTMs because mutation of a modified amino acid almost always changes the chemistry of the side chain and can be interpreted as loss-of-function. We analyzed data from ClinVar for disease variants, Minimotif Miner and the C-terminome for PTMs, and RefSeq for protein sequences, yielding 20 such potential disease-causing variants. After additional screening, they include six with a previously reported PTM disruption mechanism and nine with new hypotheses for mutated minimotifs in C-termini that may cause disease. These mutations were generally for different genes, with four different PTM types and several different diseases. Our study helps to identify new molecular mechanisms for nine separate variants that cause disease, and this type of analysis could be extended as databases grow and to binding and trafficking motifs. We conclude that mutated motifs in C-termini are an infrequent cause of disease.

Indexed as

Protein CProteinsAmino Acid SequenceHumansPhosphorylationProtein Processing, Post-TranslationalProtein CProteinsacetylationbioinformaticsC-terminusmethylationminimotifsphosphorylationpost-translational modification

Identifiers

PMID36830724
PMCPMC9953674
OpenAlexW4320496858

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.